跳至主要内容
临床试验/NCT01617252
NCT01617252已完成不适用

High Flow Nasal Oxygen Therapy for Hypoxemy After Cardiac Surgery

Nantes University Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
1
主要终点
Measure of PaO2/FiO2 ratio

研究概览

简要总结

The main objective of this study is to evaluate the gas exchange (ventilation-perfusion ratio) with the system Optiflow® compared to facial mask among patients having an acute respiratory failure after cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient with indication of coronary artery bypass
  • •Absence of preoperative respiratory failure
  • •Hypoxia after extubation defined as SpO2 < 96% with Venturi mask 50% 8L/min
  • •Age > 18 years
  • •Signed informed consent

排除标准

  • •Patients requiring an imminent intubation, in coma or respiratory exhaustion, in a state of shock or severe rhythm disorders
  • •Hemodynamic instability, low flow rate
  • •Pneumothorax or hemothorax
  • •Bleeding major, ischemic signs
  • •Ventricular arrhythmia
  • •Respiratory failure
  • •Non controlled hyperalgia
  • •Alteration of mental status
  • •Cardiac surgery patients in post-operative valve surgery associated with coronary artery bypass surgery or isolated valve surgery
  • •Pregnancy
  • •Major under guardianship

研究组 & 干预措施

Optiflow

Experimental

干预措施: Optiflow / Facial mask (Device)

Facial mask

Experimental

干预措施: Optiflow / Facial mask (Device)

结局指标

主要结局

Measure of PaO2/FiO2 ratio

时间窗: One hour and 24 hours

The main objective of this study is to evaluate the gas exchange (ventilation-perfusion ratio) with the system Optiflow® compared to facial mask among patients having an acute respiratory failure after cardiac surgery.

次要结局

  • Scale of satisfaction completed by the patient(at withdrawal of oxygen system)
  • Measure of PCO2 and respiratory frequency(One day)
  • Possibility of patient transfer in conventional service(at day 5)
  • Number of days of hospitalization(at day 28)
  • Measure of pH, SatO2, PaO2, FiO2(2 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验